Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 177 526 184 765 194 579 253 786 256 668 265 130
EBITDA 13 053 12 522 12 734 17 377 17 888 18 311
Operating profit (EBIT) 10 578 10 043 10 255 15 044 15 562 16 118
Pre-Tax Profit (EBT) 8 637 8 268 1 406 8 896 10 037 11 157
Net income 5 317 6 622 -594 6 575 7 272 8 071
P/E ratio 16,1x 11,3x -115x 15,0x 13,5x 12,1x
EPS ( $ ) 4,90 6,44 -0,57 5,01 5,60 6,22
Dividend per Share ( $ ) 1,70 2,00 2,00 1,99 1,99 2,02
Yield 2,15% 2,76% 3,05% 2,65% 2,65% 2,68%
Reference price ( $ ) 78,910 72,500 65,520 75,360 75,360 75,360
Announcement Date 02/09/2017
11:58am
02/08/2018
11:55am
02/20/2019
11:55am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 24 073 25 195 66 848 62 782 56 260 48 750
Finance - - - - - -
Operating income (EBITDA) 13 053 12 522 12 734 17 377 17 888 18 311
Leverage
(Debt/EBITDA)
1,84x 2,01x 5,25x 3,61x 3,15x 2,66x
Capital Expenditure 2 224 1 918 2 037 2 509 2 639 2 715
Free Cash Flow (FCF) 7 845 6 089 6 828 8 314 9 858 10 502
Book Value Per Share (BVPS) ( $ ) 34,7 37,2 55,8 52,4 56,5 61,1
Cash Flow per Share ( $ ) 9,33 7,82 8,49 9,05 8,84 9,02
Announcement Date 02/09/2017
11:58am
02/08/2018
11:55am
02/20/2019
11:55am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 98 041 M $ -
Entreprise Value (EV) 160 822 M $ 154 301 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 15,0x 13,5x
Capitalization / Revenue 0,39x 0,38x
EV / Revenue 0,63x 0,63x
EV / EBITDA 9,26x 8,99x
Yield (DPS / Price) 2,65% 2,65%
Price to book (Price / BVPS) 1,44x 1,33x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 5,93% 6,06%
Operating Leverage (Delta EBIT / Delta Sales) 1,53x 3,04x
Net Margin (Net Profit / Revenue) 2,59% 2,83%
ROA (Net Profit / Asset) 3,71% 3,67%
ROE (Net Profit / Equities) 12,8% 12,3%
Rate of Dividend 39,8% 35,6%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   0,99% 1,03%
Cash Flow / Sales 4,64% 4,48%
Capital Intensity (Assets / Sales) 0,70x 0,77x
Financial Leverage (Net Debt / EBITDA) 3,61x 3,15x
EPS & Dividend